Cash-settled share-based payment arrangements are a common way for companies to reward employees or acquire goods and services, where the payment is made in cash based on the value of the entity's equity instruments. While similar to equity-settled arrangements in their intent, their accounting treatment under IFRS 2 Share-based Payment differs significantly, particularly concerning disclosures. For finance professionals, a clear understanding of these specific disclosure requirements is vital to ensure accurate and transparent financial reporting.
Understanding the Arrangements
A primary disclosure requirement is to provide a clear description of the nature and terms of the cash-settled share-based payment arrangements. This includes the general terms and conditions of each arrangement, such as the vesting requirements (e.g., service conditions, performance conditions), the settlement method (always cash, but based on what underlying instrument), and any other significant features that might affect the amount of cash payable. This helps users understand the economic substance of these obligations.
Expense and Liability Recognition
Companies must disclose the total expense recognised in profit or loss during the period for cash-settled share-based payment transactions. This expense reflects the fair value of the awards at each reporting date until settlement. Additionally, the carrying amount of the liability at the end of the reporting period must be presented. This liability fluctuates with the fair value of the underlying equity instruments, the number of awards expected to vest, and the passage of time.
IFRS 2 also mandates a reconciliation of the movements in the liability for cash-settled share-based payments. This reconciliation should show the opening balance at the beginning of the period, any additions during the period (e.g., new grants), remeasurements due to changes in fair value or other estimates, payments made during the period (settlements), and the closing balance at the end of the period. This provides a comprehensive view of how the liability has changed over time.
Fair Value Measurement Details
Crucially, entities need to disclose how the fair value of the cash-settled share-based payments was determined. This includes providing the measurement date(s) used and the valuation technique employed (e.g., Black-Scholes, Monte Carlo simulation). Furthermore, information about the inputs used in that valuation technique is required. For example, if options are involved, disclosures should include the share price at measurement date, exercise price, expected volatility, expected life, expected dividends, and the risk-free interest rate. For other instruments like Share Appreciation Rights (SARs), the relevant inputs for their fair value calculation should be detailed.
Entities should also disclose information about the number of share options or other equity instruments outstanding at the beginning of the period, granted during the period, forfeited during the period, exercised during the period, and outstanding at the end of the period. While these are cash-settled, this data helps users track the volume of potential future cash outflows tied to the company's share price.
These detailed disclosures are not just regulatory hurdles; they are fundamental for transparent financial reporting. They allow investors, analysts, and other stakeholders to understand the nature, extent, and financial impact of these arrangements, assessing the company's financial health, performance, and potential future cash outflows tied to compensation schemes.
In summary, while the core accounting for cash-settled share-based payments involves recognising a liability and expense, the accompanying disclosures are equally important. Adhering to IFRS 2’s specific requirements for describing the arrangements, detailing expense and liability movements, and explaining fair value measurement provides essential insights into an entity’s obligations and valuation methods. Lux Actuaries encourages all finance professionals to pay close attention to these vital reporting elements.
Need Help With Your IFRS 2 Valuation?
Our qualified actuaries can help you with discount rate selection, assumption setting, and full IFRS 2 valuations.
Get a Quote